KETARIZO, created in 2005 (Switzerland), from 19 sister brands and 2214 competing brands. The KETARIZO brand is owned by BASILEA PHARMA, a company listed in Zurich. The International Securities Identification Number (ISIN) of BASILEA PHARMA is CH0011432447. KETARIZO is part of the Biotechnology activity sector.

KETARIZO is a brand of BASILEA PHARMA (BSLN) Share price

Share price and profitability of the share BASILEA PHARMA (KETARIZO)

Buy BASILEA PHARMA share with
(0% commission and fractional shares)
Your capital is subject to risk. Other fees apply. For more information, visit etoro.com/trading/fees.

Investment simulator :

Amount invested CHF 37.65

Portfolio valuation
BASILEA PHARMA (KETARIZO) over 5 years* CHF 30.46

Stock market history BASILEA PHARMA (KETARIZO)

Desirable brands that generate Pricing Power and therefore stock market performance

Only companies with a strong brand or unique know-how benefit from this ability to set their prices without impacting demand and thus preserve their margins.

Read more